Other
Research and development expense
Amgen Research and development expense decreased by 19.7% to $1.72B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.7%, from $1.49B to $1.72B. Over 4 years (FY 2021 to FY 2025), Research and development expense shows an upward trend with a 10.8% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Higher spending typically signals a commitment to long-term innovation and future product pipelines, while significant cuts may signal a shift toward short-term profitability.
Detailed definition
This metric captures the investment in creating new products, improving existing technologies, and advancing internal ca...
Peer comparison
Standard metric for technology and hardware firms; highly comparable to R&D spending at peers.
Metric ID:
other_research_and_development_expense_excluding_acquire_88a3cdHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.08B | $1.42B | $1.35B | $959.00M | $1.04B | $1.11B | $1.32B | $1.06B | $1.11B | $1.08B | $1.53B | $1.34B | $1.45B | $1.45B | $1.72B | $1.49B | $1.74B | $1.90B | $2.14B | $1.72B |
| QoQ Change | — | +31.4% | -5.2% | -28.9% | +8.3% | +7.0% | +19.1% | -20.1% | +5.2% | -3.1% | +42.2% | -12.5% | +7.7% | +0.2% | +18.9% | -13.8% | +17.4% | +8.9% | +12.7% | -19.7% |
| YoY Change | — | — | — | — | -4.0% | -21.8% | -1.8% | +10.3% | +7.1% | -3.0% | +15.9% | +26.9% | +30.0% | +34.4% | +12.4% | +10.6% | +20.5% | +31.0% | +24.2% | +15.7% |
Range$959.00M – $2.14B
CAGR+10.2%
Avg YoY Growth+13.0%
Median YoY Growth+14.0%
Research and development expense at Other Companies
Frequently Asked Questions
- What is Amgen's research and development expense?
- Amgen (AMGN) reported research and development expense of $1.72B in Q1 2026.
- How has Amgen's research and development expense changed year-over-year?
- Amgen's research and development expense increased by 15.7% year-over-year, from $1.49B to $1.72B.
- What is the long-term trend for Amgen's research and development expense?
- Over 4 years (2021 to 2025), Amgen's research and development expense has grown at a 10.8% compound annual growth rate (CAGR), from $4.82B to $7.27B.
- What does research and development expense mean?
- Spending on innovation and product development.